A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United States are currently living with diabetes. That’s 11.6 percent of the ...

A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Add Yahoo as a preferred source to see more of our stories on Google. The drug finerenone, made by pharma giant Bayer and marketed under the brand name Kerendia, was found to be effective in treating ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four times the total number in 1990, according to findings from a global analysis ...

A recent study reveals that intensive diabetes treatment can improve periodontal disease inflammation. Researchers found that two weeks of intensive diabetes treatment under hospitalization for ...